Citations

Clear

3057 citation(s) found for "Cd, Johnson".

Procaine Spinal Neurotoxicity
Swanson, Jerry W., Johnson, Michael E.

Mayo Clinic

Anesthesiology | March 5, 2009 | Volume: 109 | Issue: 2 | Pages: 349-351

10.1097/aln.0b013e31817fdeb8 | PMID 18648243 Get It

Pilot Study of Association of Bacteria on Breast Implants with Capsular Contracture
Pozo, José Luís del , Tran, Nho V. , Petty, Paul M., Johnson, C. H. , Walsh, Molly F., Bite, Uldis, Clay, Ricky P., Mandrekar, Jayawant N. , Piper, Kerryl E., Steckelberg, James M., Patel, Robin , Patel, Robin

Mayo Clinic

Journal of Clinical Microbiology | March 5, 2009 | Volume: 47 | Issue: 5 | Pages: 1333-1337

10.1128/jcm.00096-09 | PMID 19261794 Get It

ABSTRACT Capsular contracture is the most common and frustrating complication in women who have undergone breast implantation. Its cause and, accordingly, treatment and prevention remain to be elucidated fully. The aim of this prospective observational pilot study was to test the hypothesis that the presence of bacteria on breast implants is associated with capsular contracture. We prospectively studied consecutive patients who underwent breast implant removal for reasons other than overt infection at the Mayo Clinic from February through September 2008. Removed breast implants were processed using a vortexing/sonication procedure and then subjected to semiquantitative culture. Twenty-seven of the 45 implants collected were removed due to significant capsular contracture, among which 9 (33%) had ≥20 CFU bacteria/10 ml sonicate fluid; 18 were removed for reasons other than significant capsular contracture, among which 1 (5%) had ≥20 CFU/10 ml sonicate fluid ( P = 0.034). Propionibacterium species, coagulase-negative staphylococci, and Corynebacterium species were the microorganisms isolated. The results of this study demonstrate that there is a significant association between capsular contracture and the presence of bacteria on the implant. The role of these bacteria in the pathogenesis of capsular contracture deserves further study.
Propofol Infusion and Lactic Acidosis
Cravens, Grant T., Johnson, Michael E.

Mayo Clinic

Anesthesiology | March 5, 2009 | Volume: 108 | Issue: 2 | Pages: 331-332

10.1097/01.anes.0000300065.01029.c9 | PMID 18212581 Get It

Evaluation of a New Mechanical Pressure Tester for Barrier Fabrics
McCullough, EA, Johnson, P.V.

Mayo Clinic

Performance of Protective Clothing: Sixth Volume | March 4, 2009 | Volume: No volume available | Issue: No issue available | Pages: 37-46

10.1520/stp19891s Get It

ASTM F23.40.04, Draft Test Method for the Resistance of Materials Used in Protective Clothing to Penetration by Synthetic Blood Using a Mechanical Pressure Technique, was evaluated and compared to three other barrier test methods that apply hydrostatic pressure to the liquid and fabric. The new instrument applies continuous mechanical pressure to the fabric and synthetic blood until penetration is visible, and the penetration pressure level is recorded. The barrier properties of 14 different surgical gown materials and control fabrics were measured using the new method and ASTM F 1670 and F 1671 and AATCC 127. Surgical gown materials reinforced with films, coatings, or membranes passed ASTM F 1670 and F 1671 and reached the highest pressure level attainable on the AATCC 127 and ASTM F23.40.04 tests. Single-layer and fabric reinforced gowns exhibited varying degrees of liquid resistance. The new method simulates the high mechanical pressures of short duration that occur during surgery. It deserves consideration as a standard.
Diagnostic Utility of T1-Weighted MRI Characteristics in Evaluation of Osteomyelitis of the Foot
Johnson, Paul W., Collins, Mark S., Wenger, Doris E.

Mayo Clinic

American Journal of Roentgenology | December 19, 2008 | Volume: 192 | Issue: 1 | Pages: 96-100

10.2214/ajr.08.1376 | PMID 19098186 Get It

Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy
Johnson, Jonathan N. , Hofman, Nynke , Haglund, Carla M., Cascino, Gregory D. , Wilde, Arthur A.M. , Ackerman, Michael J.

Mayo Clinic

Neurology | November 27, 2008 | Volume: 72 | Issue: 3 | Pages: 224-231

10.1212/01.wnl.0000335760.02995.ca | PMID 19038855 Get It

Relationship Between Parenting Stress and Concerns Identified by Developmental Screening and Their Effects on Parental Medical Care—Seeking Behavior
Voigt, Robert G. , Johnson, Shirley K., Mellon, Michael W., Hashikawa, Andrew N. , Campeau, Lynnelle J., Williams, Arthur R., Yawn, Barbara P. , Juhn, Young J.

Mayo Clinic

Clinical Pediatrics | November 20, 2008 | Volume: 48 | Issue: 4 | Pages: 362-368

10.1177/0009922808327058 | PMID 19023111 Get It

This cross-sectional study examines the relationship between parenting stress and concerns identified by developmental screening and their effects on parents' decisions to seek medical care for their children. A total of 182 parents completed both the Parenting Stress Index (PSI) and the Parents' Evaluation of Developmental Status (PEDS) when their children were admitted to a sick child care program that provides parents the option of requesting medical evaluations for their children with mild acute illnesses. Although 31.6% of parents (N = 62) requested medical evaluations, neither PSI nor PEDS scores were associated with these requests. However, PEDS scores indicating significant parental concerns about their child's development or behavior predicted clinically significant levels of parenting stress on the PSI (odds ratio 4.9; 95% confidence interval, 1.5-15.9; P = .007). Primary pediatric health care providers who routinely perform developmental screening need to consider this relationship when interpreting developmental screening results and offer supportive and referral services to families as needed.
Analysis of the Reaction of Carbachol with Acetylcholinesterase Using Thioflavin T As a Coupled Fluorescence Reporter
Rosenberry, Terrone L. , Sonoda, Leilani K., Dekat, Sarah E., Cusack, Bernadette, Johnson, Joseph L.

Mayo Clinic

Biochemistry | November 12, 2008 | Volume: 47 | Issue: 49 | Pages: 13056-13063

10.1021/bi8015197 | PMID 19006330 Get It

Liver Is the Site of Splanchnic Cortisol Production in Obese Nondiabetic Humans
Basu, Rita , Basu, Ananda , Grudzień, M, Jung, Paul , Jacobson, Peer B., Johnson, Michael C., Sarr, Michael G. , Rizza, Robert A., Singh, Ravinder J.

Mayo Clinic

Diabetes | October 14, 2008 | Volume: 58 | Issue: 1 | Pages: 39-45

10.2337/db08-1079 | PMID 18852327 Get It

OBJECTIVE—To determine the contribution of liver and viscera to splanchnic cortisol production in humans. RESEARCH DESIGN AND METHODS—D4 cortisol was infused intravenously; arterial, portal venous, and hepatic venous blood was sampled; and liver and visceral fat were biopsied in subjects undergoing bariatric surgery. RESULTS—Ratios of arterial and portal vein D4 cortisol/cortisoltotal (0.06 ± 0.01 vs. 0.06 ± 0.01) and D4 cortisol/D3 cortisol (1.80 ± 0.14 vs. 1.84 ± 0.14) did not differ, indicating that no visceral cortisol production or conversion of D4 cortisol to D3 cortisol via 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) occurred. Conversely, ratios of both D4 cortisol to cortisoltotal (0.05 ± 0.01; P < 0.05) and D4 cortisol to D3 cortisol (1.33 ± 0.11; P < 0.001) were lower in the hepatic vein than in the portal vein, indicating production of both cortisol and D3 cortisol by the liver. The viscera did not produce either cortisol (−8.1 ± 2.6 μg/min) or D3 cortisol (−0.2 ± 0.1 μg/min). In contrast, the liver produced both cortisol (22.7 ± 3.90 μg/min) and D3 cortisol (1.9 ± 0.4 μg/min) and accounted for all splanchnic cortisol and D3 cortisol production. Additionally, 11β-HSD-1 mRNA was approximately ninefold higher (P < 0.01) in liver than in visceral fat. Although 11β-HSD-2 gene expression was very low in visceral fat, the viscera released cortisone (P < 0.001) and D3 cortisone (P < 0.01) into the portal vein. CONCLUSIONS—The liver accounts for all splanchnic cortisol production in obese nondiabetic humans. In contrast, the viscera releases cortisone into the portal vein, thereby providing substrate for intrahepatic cortisol production.
Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humans
Snyder, Eric M., Carr, Richard D., Deacon, Carolyn F. , Johnson, Bruce

Mayo Clinic

Applied Physiology, Nutrition, and Metabolism | October 10, 2008 | Volume: 33 | Issue: 5 | Pages: 929-935

10.1139/h08-079 | PMID 18923568 Get It

Altitude exposure has been associated with loss of appetite and weight loss in healthy humans; however, the endocrine factors that contribute to these changes remain unclear. Leptin and glucagon-like peptide-1 (GLP-1) are peptide hormones that contribute to the regulation of appetite. Leptin increases with hypoxia; however, the influence of hypoxia on GLP-1 has not been studied in animals or humans to date. We sought to determine the influence of normobaric hypoxia on plasma leptin and GLP-1 levels in 25 healthy humans. Subjects ingested a control meal during normoxia and after 17 h of exposure to normobaric hypoxia (fraction of inspired oxygen of 12.5%, simulating approximately 4100 m). Plasma leptin was assessed before the meal, and GLP-1 was assessed premeal, at 20 min postmeal, and at 40 min postmeal. We found that hypoxia caused a significant elevation in plasma leptin levels (normoxia, 4.9 ± 0.8 pg·mL–1; hypoxia, 7.7 ± 1.5 pg·mL–1; p < 0.05; range, –16% to 190%), no change in the average GLP-1 response to hypoxia, and only a small trend toward an increase in GLP-1 levels 40 min postmeal (fasting, 15.7 ± 0.9 vs 15.9 ± 0.7 pmol·L–1; 20 min postmeal, 21.7 ± 0.9 vs 21.8 ± 1.2 pmol·L–1; 40 min postmeal, 19.5 ± 1.2 vs. 21.0 ± 1.2 pmol·L–1 for normoxia and hypoxia, respectively; p > 0.05 normoxia vs hypoxia). There was a correlation between SaO2 and leptin after the 17 h exposure (r = 0.45; p < 0.05), but no relation between SaO2 and GLP-1. These data confirm that leptin increases with hypoxic exposure in humans. Further study is needed to determine the influence of hypoxia and altitude on GLP-1 levels.